Literature DB >> 20814763

Treatment for non-dysplastic Barrett's oesophagus: a well-informed, demanding patient.

Luigi Dall'Olmo1, Lorenzo Moja.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20814763     DOI： 10.1007/s11739-010-0453-y

Source DB:  PubMed          Journal:  Intern Emerg Med        ISSN： 1828-0447            Impact factor:   3.397


× No keyword cloud information.
  6 in total

1.  Long-term results of a randomized prospective study comparing medical and surgical treatment of Barrett's esophagus.

Authors:  Pascual Parrilla; Luisa F Martínez de Haro; Angeles Ortiz; Vicente Munitiz; Joaquín Molina; Juan Bermejo; Manuel Canteras
Journal:  Ann Surg       Date:  2003-03       Impact factor: 12.969

2.  Updated guidelines 2008 for the diagnosis, surveillance and therapy of Barrett's esophagus.

Authors:  Kenneth K Wang; Richard E Sampliner
Journal:  Am J Gastroenterol       Date:  2008-03       Impact factor: 10.864

Review 3.  Gastroesophageal reflux disease and Barrett's esophagus.

Authors:  Dino Vaira; Luigi Gatta; Chiara Ricci; Valentina Castelli; Giulia Fiorini; Enkeleda Kajo; Alberto Lanzini
Journal:  Intern Emerg Med       Date:  2010-07-08       Impact factor: 3.397

Review 4.  Treatment for Barrett's oesophagus.

Authors:  Jonathan Re Rees; Pierre Lao-Sirieix; Angela Wong; Rebecca C Fitzgerald
Journal:  Cochrane Database Syst Rev       Date:  2010-01-20

Review 5.  Risk of esophageal adenocarcinoma and mortality in patients with Barrett's esophagus: a systematic review and meta-analysis.

Authors:  Marjolein Sikkema; Pieter J F de Jonge; Ewout W Steyerberg; Ernst J Kuipers
Journal:  Clin Gastroenterol Hepatol       Date:  2009-10-20       Impact factor: 11.382

6.  An antiapoptotic role for gastrin and the gastrin/CCK-2 receptor in Barrett's esophagus.

Authors:  Joseph C Harris; Philip A Clarke; Altaf Awan; Janusz Jankowski; Susan A Watson
Journal:  Cancer Res       Date:  2004-03-15       Impact factor: 12.701
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.